Caryocar	B:C3818737
brasiliense	I:C3818737
oil	I:C3818737
improves	O
cardiac	O
function	I:C0232164
by	O
increasing	O
Serca2a	O
/	O
phospholanban	O
ratio	O
despite	O
no	O
significant	O
changes	O
in	O
cardiovascular	O
risk	O
factors	O
in	O
rats	O
.	O

Caryocar	O
brasiliense	I:C3818737
oil	I:C3818737
improves	B:C0184511
cardiac	O
function	I:C0232164
by	O
increasing	O
Serca2a	O
/	O
phospholanban	O
ratio	O
despite	O
no	O
significant	O
changes	O
in	O
cardiovascular	O
risk	O
factors	O
in	O
rats	O
.	O

Caryocar	O
brasiliense	I:C3818737
oil	I:C3818737
improves	O
cardiac	B:C0232164
function	I:C0232164
by	O
increasing	O
Serca2a	O
/	O
phospholanban	O
ratio	O
despite	O
no	O
significant	O
changes	O
in	O
cardiovascular	O
risk	O
factors	O
in	O
rats	O
.	O

Caryocar	O
brasiliense	I:C3818737
oil	I:C3818737
improves	O
cardiac	O
function	I:C0232164
by	O
increasing	O
Serca2a	B:C1455616
/	O
phospholanban	O
ratio	O
despite	O
no	O
significant	O
changes	O
in	O
cardiovascular	O
risk	O
factors	O
in	O
rats	O
.	O

Caryocar	O
brasiliense	I:C3818737
oil	I:C3818737
improves	O
cardiac	O
function	I:C0232164
by	O
increasing	O
Serca2a	O
/	O
phospholanban	B:C0070876
ratio	O
despite	O
no	O
significant	O
changes	O
in	O
cardiovascular	O
risk	O
factors	O
in	O
rats	O
.	O

Caryocar	O
brasiliense	I:C3818737
oil	I:C3818737
improves	O
cardiac	O
function	I:C0232164
by	O
increasing	O
Serca2a	O
/	O
phospholanban	O
ratio	O
despite	O
no	O
significant	O
changes	O
in	O
cardiovascular	O
risk	O
factors	O
in	O
rats	B:C0086893
.	O

Caryocar	B:C3818737
brasiliense	I:C3818737
(	I:C3818737
pequi	I:C3818737
)	I:C3818737
oil	I:C3818737
is	O
high	O
in	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
(	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
)	O
,	O
especially	O
oleic	O
,	O
and	O
in	O
carotenoids	O
,	O
which	O
have	O
been	O
associated	O
with	O
protection	O
against	O
cardiovascular	O
disease	I:C0007222
.	O

Caryocar	O
brasiliense	I:C3818737
(	I:C3818737
pequi	I:C3818737
)	I:C3818737
oil	I:C3818737
is	O
high	O
in	O
monounsaturated	B:C0015687
fat	I:C0015687
acids	I:C0015687
(	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
)	O
,	O
especially	O
oleic	O
,	O
and	O
in	O
carotenoids	O
,	O
which	O
have	O
been	O
associated	O
with	O
protection	O
against	O
cardiovascular	O
disease	I:C0007222
.	O

Caryocar	O
brasiliense	I:C3818737
(	I:C3818737
pequi	I:C3818737
)	I:C3818737
oil	I:C3818737
is	O
high	O
in	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
(	O
monounsaturated	B:C0015687
fat	I:C0015687
acids	I:C0015687
)	O
,	O
especially	O
oleic	O
,	O
and	O
in	O
carotenoids	O
,	O
which	O
have	O
been	O
associated	O
with	O
protection	O
against	O
cardiovascular	O
disease	I:C0007222
.	O

Caryocar	O
brasiliense	I:C3818737
(	I:C3818737
pequi	I:C3818737
)	I:C3818737
oil	I:C3818737
is	O
high	O
in	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
(	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
)	O
,	O
especially	O
oleic	B:C0028928
,	O
and	O
in	O
carotenoids	O
,	O
which	O
have	O
been	O
associated	O
with	O
protection	O
against	O
cardiovascular	O
disease	I:C0007222
.	O

Caryocar	O
brasiliense	I:C3818737
(	I:C3818737
pequi	I:C3818737
)	I:C3818737
oil	I:C3818737
is	O
high	O
in	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
(	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
)	O
,	O
especially	O
oleic	O
,	O
and	O
in	O
carotenoids	B:C0007271
,	O
which	O
have	O
been	O
associated	O
with	O
protection	O
against	O
cardiovascular	O
disease	I:C0007222
.	O

Caryocar	O
brasiliense	I:C3818737
(	I:C3818737
pequi	I:C3818737
)	I:C3818737
oil	I:C3818737
is	O
high	O
in	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
(	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
)	O
,	O
especially	O
oleic	O
,	O
and	O
in	O
carotenoids	O
,	O
which	O
have	O
been	O
associated	O
with	O
protection	O
against	O
cardiovascular	B:C0007222
disease	I:C0007222
.	O

However	O
,	O
this	O
food	B:C0016452
is	O
poorly	O
studied	O
in	O
this	O
context	O
,	O
especially	O
in	O
the	O
cardiac	O
function	I:C0232164
.	O

However	O
,	O
this	O
food	O
is	O
poorly	O
studied	O
in	O
this	O
context	O
,	O
especially	O
in	O
the	O
cardiac	B:C0232164
function	I:C0232164
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
a	O
long	O
-	O
term	O
intake	O
of	O
pequi	B:C3818737
oil	I:C3818737
in	O
systemic	O
cardiovascular	O
risk	O
factors	O
and	O
in	O
the	O
ex	O
vivo	O
cardiac	O
function	I:C0232164
of	O
rats	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
a	O
long	O
-	O
term	O
intake	O
of	O
pequi	O
oil	I:C3818737
in	O
systemic	O
cardiovascular	O
risk	O
factors	O
and	O
in	O
the	O
ex	O
vivo	O
cardiac	B:C0232164
function	I:C0232164
of	O
rats	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
a	O
long	O
-	O
term	O
intake	O
of	O
pequi	O
oil	I:C3818737
in	O
systemic	O
cardiovascular	O
risk	O
factors	O
and	O
in	O
the	O
ex	O
vivo	O
cardiac	O
function	I:C0232164
of	O
rats	B:C0086893
.	O

Previously	O
,	O
we	O
determined	O
fatty	B:C0015684
acids	I:C0015684
and	O
carotenoids	O
in	O
pequi	O
oil	I:C3818737
.	O

Previously	O
,	O
we	O
determined	O
fatty	O
acids	I:C0015684
and	O
carotenoids	B:C0007271
in	O
pequi	O
oil	I:C3818737
.	O

Previously	O
,	O
we	O
determined	O
fatty	O
acids	I:C0015684
and	O
carotenoids	O
in	O
pequi	B:C3818737
oil	I:C3818737
.	O

Next	O
,	O
male	O
rats	B:C0086893
were	O
divided	O
in	O
C	O
-	O
control	O
group	O
feed	O
a	O
standard	O
diet	O
,	O
and	O
PO	O
-	O
pequi	O
oil	I:C3818737
group	O
fed	O
the	O
same	O
diet	O
added	O
pequi	O
oil	I:C3818737
(	O
+2.25	O
g.100	O
g	O
(	O
-	O
1	O
)	O
)	O
.	O

Next	O
,	O
male	O
rats	O
were	O
divided	O
in	O
C	O
-	O
control	O
group	O
feed	O
a	O
standard	O
diet	O
,	O
and	O
PO	B:C3818737
-	O
pequi	O
oil	I:C3818737
group	O
fed	O
the	O
same	O
diet	O
added	O
pequi	O
oil	I:C3818737
(	O
+2.25	O
g.100	O
g	O
(	O
-	O
1	O
)	O
)	O
.	O

Next	O
,	O
male	O
rats	O
were	O
divided	O
in	O
C	O
-	O
control	O
group	O
feed	O
a	O
standard	O
diet	O
,	O
and	O
PO	O
-	O
pequi	B:C3818737
oil	I:C3818737
group	O
fed	O
the	O
same	O
diet	O
added	O
pequi	O
oil	I:C3818737
(	O
+2.25	O
g.100	O
g	O
(	O
-	O
1	O
)	O
)	O
.	O

Next	O
,	O
male	O
rats	O
were	O
divided	O
in	O
C	O
-	O
control	O
group	O
feed	O
a	O
standard	O
diet	O
,	O
and	O
PO	O
-	O
pequi	O
oil	I:C3818737
group	O
fed	O
the	O
same	O
diet	O
added	O
pequi	B:C3818737
oil	I:C3818737
(	O
+2.25	O
g.100	O
g	O
(	O
-	O
1	O
)	O
)	O
.	O

After	O
15	O
weeks	O
,	O
plasma	B:C0032105
lipids	O
,	O
glucose	O
,	O
insulin	O
,	O
blood	O
pressure	I:C0005823
,	O
heart	O
rate	I:C0018810
,	O
hepatic	O
lipids	I:C0023779
were	O
accessed	O
and	O
visceral	O
fat	I:C1563740
pads	I:C1563740
were	O
harvested	O
.	O

After	O
15	O
weeks	O
,	O
plasma	O
lipids	B:C0023779
,	O
glucose	O
,	O
insulin	O
,	O
blood	O
pressure	I:C0005823
,	O
heart	O
rate	I:C0018810
,	O
hepatic	O
lipids	I:C0023779
were	O
accessed	O
and	O
visceral	O
fat	I:C1563740
pads	I:C1563740
were	O
harvested	O
.	O

After	O
15	O
weeks	O
,	O
plasma	O
lipids	O
,	O
glucose	B:C0017725
,	O
insulin	O
,	O
blood	O
pressure	I:C0005823
,	O
heart	O
rate	I:C0018810
,	O
hepatic	O
lipids	I:C0023779
were	O
accessed	O
and	O
visceral	O
fat	I:C1563740
pads	I:C1563740
were	O
harvested	O
.	O

After	O
15	O
weeks	O
,	O
plasma	O
lipids	O
,	O
glucose	O
,	O
insulin	B:C0021641
,	O
blood	O
pressure	I:C0005823
,	O
heart	O
rate	I:C0018810
,	O
hepatic	O
lipids	I:C0023779
were	O
accessed	O
and	O
visceral	O
fat	I:C1563740
pads	I:C1563740
were	O
harvested	O
.	O

After	O
15	O
weeks	O
,	O
plasma	O
lipids	O
,	O
glucose	O
,	O
insulin	O
,	O
blood	B:C0005823
pressure	I:C0005823
,	O
heart	O
rate	I:C0018810
,	O
hepatic	O
lipids	I:C0023779
were	O
accessed	O
and	O
visceral	O
fat	I:C1563740
pads	I:C1563740
were	O
harvested	O
.	O

After	O
15	O
weeks	O
,	O
plasma	O
lipids	O
,	O
glucose	O
,	O
insulin	O
,	O
blood	O
pressure	I:C0005823
,	O
heart	B:C0018810
rate	I:C0018810
,	O
hepatic	O
lipids	I:C0023779
were	O
accessed	O
and	O
visceral	O
fat	I:C1563740
pads	I:C1563740
were	O
harvested	O
.	O

After	O
15	O
weeks	O
,	O
plasma	O
lipids	O
,	O
glucose	O
,	O
insulin	O
,	O
blood	O
pressure	I:C0005823
,	O
heart	O
rate	I:C0018810
,	O
hepatic	B:C0023779
lipids	I:C0023779
were	O
accessed	O
and	O
visceral	O
fat	I:C1563740
pads	I:C1563740
were	O
harvested	O
.	O

After	O
15	O
weeks	O
,	O
plasma	O
lipids	O
,	O
glucose	O
,	O
insulin	O
,	O
blood	O
pressure	I:C0005823
,	O
heart	O
rate	I:C0018810
,	O
hepatic	O
lipids	I:C0023779
were	O
accessed	O
and	O
visceral	B:C1563740
fat	I:C1563740
pads	I:C1563740
were	O
harvested	O
.	O

Hearts	B:C0018787
were	O
used	O
for	O
the	O
ex	O
vivo	O
cardiac	O
function	I:C0232164
,	O
histologic	O
assays	I:C0019637
,	O
SERCA2a	O
and	O
phospholanban	O
(	O
phospholanban	O
)	O
determinations	O
.	O

Hearts	O
were	O
used	O
for	O
the	O
ex	O
vivo	O
cardiac	B:C0232164
function	I:C0232164
,	O
histologic	O
assays	I:C0019637
,	O
SERCA2a	O
and	O
phospholanban	O
(	O
phospholanban	O
)	O
determinations	O
.	O

Hearts	O
were	O
used	O
for	O
the	O
ex	O
vivo	O
cardiac	O
function	I:C0232164
,	O
histologic	B:C0019637
assays	I:C0019637
,	O
SERCA2a	O
and	O
phospholanban	O
(	O
phospholanban	O
)	O
determinations	O
.	O

Hearts	O
were	O
used	O
for	O
the	O
ex	O
vivo	O
cardiac	O
function	I:C0232164
,	O
histologic	O
assays	I:C0019637
,	O
SERCA2a	B:C1455616
and	O
phospholanban	O
(	O
phospholanban	O
)	O
determinations	O
.	O

Hearts	O
were	O
used	O
for	O
the	O
ex	O
vivo	O
cardiac	O
function	I:C0232164
,	O
histologic	O
assays	I:C0019637
,	O
SERCA2a	O
and	O
phospholanban	B:C0070876
(	O
phospholanban	O
)	O
determinations	O
.	O

Hearts	O
were	O
used	O
for	O
the	O
ex	O
vivo	O
cardiac	O
function	I:C0232164
,	O
histologic	O
assays	I:C0019637
,	O
SERCA2a	O
and	O
phospholanban	O
(	O
phospholanban	B:C0070876
)	O
determinations	O
.	O

In	O
agreement	O
with	O
scientific	O
data	O
,	O
pequi	B:C3818737
oil	I:C3818737
had	O
expressive	O
amounts	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
,	O
especially	O
oleic	O
acid	I:C0028928
,	O
and	O
carotenoids	O
.	O

In	O
agreement	O
with	O
scientific	O
data	O
,	O
pequi	O
oil	I:C3818737
had	O
expressive	O
amounts	O
monounsaturated	B:C0015687
fat	I:C0015687
acids	I:C0015687
,	O
especially	O
oleic	O
acid	I:C0028928
,	O
and	O
carotenoids	O
.	O

In	O
agreement	O
with	O
scientific	O
data	O
,	O
pequi	O
oil	I:C3818737
had	O
expressive	O
amounts	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
,	O
especially	O
oleic	B:C0028928
acid	I:C0028928
,	O
and	O
carotenoids	O
.	O

In	O
agreement	O
with	O
scientific	O
data	O
,	O
pequi	O
oil	I:C3818737
had	O
expressive	O
amounts	O
monounsaturated	O
fat	I:C0015687
acids	I:C0015687
,	O
especially	O
oleic	O
acid	I:C0028928
,	O
and	O
carotenoids	B:C0007271
.	O

Hepatic	B:C0041004
triglycerides	I:C0041004
(	O
triglycerides	O
)	O
were	O
reduced	O
by	O
pequi	O
oil	I:C3818737
intake	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Hepatic	O
triglycerides	I:C0041004
(	O
triglycerides	B:C0041004
)	O
were	O
reduced	O
by	O
pequi	O
oil	I:C3818737
intake	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Hepatic	O
triglycerides	I:C0041004
(	O
triglycerides	O
)	O
were	O
reduced	O
by	O
pequi	B:C3818737
oil	I:C3818737
intake	O
(	O
p	O
<	O
0.05	O
)	O
.	O

The	O
intrinsic	B:C0205102
heart	O
rate	I:C0018810
was	O
lower	O
in	O
PO	O
group	O
(	O
p	O
<	O
0.05	O
)	O
.	O

The	O
intrinsic	O
heart	B:C0018810
rate	I:C0018810
was	O
lower	O
in	O
PO	O
group	O
(	O
p	O
<	O
0.05	O
)	O
.	O

The	O
intrinsic	O
heart	O
rate	I:C0018810
was	O
lower	O
in	O
PO	B:C3818737
group	O
(	O
p	O
<	O
0.05	O
)	O
.	O

SERCA2a	B:C1455616
content	O
was	O
higher	O
in	O
this	O
group	O
(	O
p	O
<	O
0.05	O
)	O
,	O
without	O
affecting	O
phospholanban	O
.	O

SERCA2a	O
content	O
was	O
higher	O
in	O
this	O
group	O
(	O
p	O
<	O
0.05	O
)	O
,	O
without	O
affecting	O
phospholanban	B:C0070876
.	O

Also	O
,	O
SERCA2a	B:C1455616
/	O
phospholanban	O
ratio	O
increased	O
in	O
PO	O
group	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Also	O
,	O
SERCA2a	O
/	O
phospholanban	B:C0070876
ratio	O
increased	O
in	O
PO	O
group	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Also	O
,	O
SERCA2a	O
/	O
phospholanban	O
ratio	O
increased	O
in	O
PO	B:C3818737
group	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Pequi	B:C3818737
oil	I:C3818737
intake	O
improved	O
cardiac	O
function	I:C0232164
ex	O
vivo	O
,	O
despite	O
no	O
significant	O
changes	O
in	O
systemic	O
cardiovascular	O
risk	O
factors	O
.	O

Pequi	O
oil	I:C3818737
intake	O
improved	B:C0184511
cardiac	O
function	I:C0232164
ex	O
vivo	O
,	O
despite	O
no	O
significant	O
changes	O
in	O
systemic	O
cardiovascular	O
risk	O
factors	O
.	O

Pequi	O
oil	I:C3818737
intake	O
improved	O
cardiac	B:C0232164
function	I:C0232164
ex	O
vivo	O
,	O
despite	O
no	O
significant	O
changes	O
in	O
systemic	O
cardiovascular	O
risk	O
factors	O
.	O

The	O
higher	O
lipid	B:C0023779
offer	O
in	O
pequi	O
oil	I:C3818737
diet	O
,	O
its	O
composition	O
in	O
oleic	O
acid	I:C0028928
and	O
carotenoids	O
could	O
be	O
related	O
to	O
those	O
effects	O
.	O

The	O
higher	O
lipid	O
offer	O
in	O
pequi	B:C3818737
oil	I:C3818737
diet	O
,	O
its	O
composition	O
in	O
oleic	O
acid	I:C0028928
and	O
carotenoids	O
could	O
be	O
related	O
to	O
those	O
effects	O
.	O

The	O
higher	O
lipid	O
offer	O
in	O
pequi	O
oil	I:C3818737
diet	B:C0012155
,	O
its	O
composition	O
in	O
oleic	O
acid	I:C0028928
and	O
carotenoids	O
could	O
be	O
related	O
to	O
those	O
effects	O
.	O

The	O
higher	O
lipid	O
offer	O
in	O
pequi	O
oil	I:C3818737
diet	O
,	O
its	O
composition	O
in	O
oleic	B:C0028928
acid	I:C0028928
and	O
carotenoids	O
could	O
be	O
related	O
to	O
those	O
effects	O
.	O

The	O
higher	O
lipid	O
offer	O
in	O
pequi	O
oil	I:C3818737
diet	O
,	O
its	O
composition	O
in	O
oleic	O
acid	I:C0028928
and	O
carotenoids	B:C0007271
could	O
be	O
related	O
to	O
those	O
effects	O
.	O

